+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

From
From
Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035 - Product Thumbnail Image

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

  • Report
  • February 2023
  • 243 Pages
  • Asia Pacific
From
Rare Diseases Treatment Market Report 2025 - Product Thumbnail Image

Rare Diseases Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Glioma Treatment Market Report 2025 - Product Thumbnail Image

Glioma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Breast Cancer Drugs Market Report 2025 - Product Thumbnail Image

Breast Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alzheimer's Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Lung Cancer Drugs Market Report 2025 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator